DEVELOPMENT OF HERPETIC VECTORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM-CONFINED DISEASES

Pubblicazioni Scientifiche

• 2001 JOURNAL OF IMMUNOLOGY

  Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes

• 2000 GENE THERAPY

  Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors

• 2000 JOURNAL OF NEUROIMMUNOLOGY

  Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach

• 2001 HUMAN GENE THERAPY

  Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis

• 2001 TRENDS IN IMMUNOLOGY

  The ependymal route to the CNS: an emerging gene-therapy approach for MS

• 2001 GENE THERAPY

  Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice

• 2001 GENE THERAPY

  Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice